Amplified Fragment Length Polymorphism Analysis × Clear all Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma
Phase 1/2 Completed
138 enrolled 16 charts
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
Phase 1 Completed
46 enrolled
Oxaliplatin - Induced Peripheral Neuropathy in Patients With Gastrointestinal Tract Cancer
Unknown
80 enrolled
Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer
Phase 2 Completed
5 enrolled 10 charts
Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery
Phase 2 Terminated
3 enrolled 6 charts
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia
Active not recruiting
600 enrolled
Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
Terminated
114 enrolled 8 charts
CML0408
Phase 2 Completed
129 enrolled
Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer
Completed
748 enrolled
SOLE-EST
Completed
104 enrolled 13 charts
Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient
Unknown
100 enrolled
Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
Phase 1/2 Completed
58 enrolled 12 charts
Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients
Unknown
100 enrolled
Genes in Predicting Outcome in Patients With Esophageal Cancer Treated With Cisplatin, Radiation Therapy, and Surgery
Completed
118 enrolled
Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496
Completed
175 enrolled
Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia
Phase 1/2 Completed
22 enrolled 9 charts
Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck
Phase 2 Terminated
2 enrolled 8 charts
Study of Tumor and Blood Samples From Postmenopausal Women With Primary Breast Cancer Enrolled on Clinical Trial CAN-NCIC-MA27
Completed
364 enrolled
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
Phase 2 Unknown
48 enrolled
Study of Blood and Cheek Cell Samples From Patients With Glioma
Completed
1,709 enrolled
Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome
Phase 1/2 Completed
25 enrolled 13 charts
Study of Tumor Samples in Patients Undergoing Treatment for Gastrointestinal Stromal Tumors on Clinical Trial ACOSOG-Z9001
Completed
1 enrolled
Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Terminated
1,000 enrolled
S0916, MLN1202 in Treating Patients With Bone Metastases
Phase 2 Completed
44 enrolled 7 charts
Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy
Terminated
10 enrolled
S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma
Completed
91 enrolled
Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer
Phase 2 Completed
73 enrolled 16 charts
PACE in BC
Completed
133 enrolled
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia
Unknown
1,200 enrolled
Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
Completed
248 enrolled
Study of DNA Samples From Patients With Multiple Myeloma
Completed
600 enrolled
DNA Changes in Patients With Prostate Cancer
Completed
646 enrolled
Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel
Completed
180 enrolled
Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer
Phase 2 Completed
53 enrolled 10 charts
Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803
Completed
37 enrolled
Study of Bone Marrow Samples From Patients With Acute Leukemia
Completed
40 enrolled
Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based Therapy
Completed
225 enrolled
Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab
Completed
559 enrolled
Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab
Completed
363 enrolled
Studying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 Trial
Completed
183 enrolled
DNA Changes That Affect Vitamin D Metabolism in Patients With Colorectal Cancer Receiving Vitamin D Supplements
Phase NA Completed
50 enrolled
Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer
Completed
400 enrolled
SWOG 8897-A DNA Analysis in Predicting Treatment Outcome in Women With Breast Cancer in SWOG 8897
Completed
1,577 enrolled
S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and Goserelin
Completed
545 enrolled
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Completed
140 enrolled
Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer
Completed
31 enrolled
Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer
Completed
265 enrolled
DNA Variations in the Gene in Young Patients With Wilms' Tumor
Completed
471 enrolled
Biomarker Changes in Samples From Young Patients With Acute Myeloid Leukemia
Completed
15 enrolled
Biomarkers in Young Patients With Neuroblastoma
Completed
380 enrolled